MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,000 | +2.9% | 507 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $34,000 | -10.5% | 507 | +8.8% | 0.01% | 0.0% |
| Q1 2022 | $38,000 | -30.9% | 466 | +23.9% | 0.01% | -28.6% |
| Q4 2021 | $55,000 | -16.7% | 376 | 0.0% | 0.01% | -22.2% |
| Q3 2021 | $66,000 | +10.0% | 376 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $60,000 | +81.8% | 376 | +91.8% | 0.01% | +60.0% |
| Q1 2021 | $33,000 | – | 196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |